pubmed-article:10422874 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10422874 | lifeskim:mentions | umls-concept:C0015967 | lld:lifeskim |
pubmed-article:10422874 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
pubmed-article:10422874 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:10422874 | lifeskim:mentions | umls-concept:C1144709 | lld:lifeskim |
pubmed-article:10422874 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:10422874 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
pubmed-article:10422874 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:10422874 | pubmed:dateCreated | 1999-9-21 | lld:pubmed |
pubmed-article:10422874 | pubmed:abstractText | The effects of atrial natriuretic peptide (ANP-28), brain natriuretic peptide (BNP-32) and C-type natriuretic peptide (CNP-22) on body temperature were investigated in rats. Intracerebroventricular administration of each peptide in doses of 400 or 1000 ng caused a dose-related elevation in colon temperature 30 and 60 min after injection. A 40 ng dose of ANP-28 was also hyperthermic at 60 min. An intramuscular (i.m.) injection of noraminophenazone (a cyclooxygenase inhibitor) abolished the natriuretic peptide-induced hyperthermia. The results show that natriuretic peptides may participate in thermoregulatory processes in the central nervous system, and that their hyperthermic effect may be mediated via a cyclooxygenase-involved pathway. | lld:pubmed |
pubmed-article:10422874 | pubmed:language | eng | lld:pubmed |
pubmed-article:10422874 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10422874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10422874 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10422874 | pubmed:issn | 0196-9781 | lld:pubmed |
pubmed-article:10422874 | pubmed:author | pubmed-author:TelegdyGG | lld:pubmed |
pubmed-article:10422874 | pubmed:author | pubmed-author:PatakiII | lld:pubmed |
pubmed-article:10422874 | pubmed:author | pubmed-author:JászberényiMM | lld:pubmed |
pubmed-article:10422874 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10422874 | pubmed:volume | 20 | lld:pubmed |
pubmed-article:10422874 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10422874 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10422874 | pubmed:pagination | 193-7 | lld:pubmed |
pubmed-article:10422874 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:meshHeading | pubmed-meshheading:10422874... | lld:pubmed |
pubmed-article:10422874 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10422874 | pubmed:articleTitle | Hyperthermic effect of centrally administered natriuretic peptides in the rat. | lld:pubmed |
pubmed-article:10422874 | pubmed:affiliation | Department of Pathophysiology, Albert Szent-Györgyi Medical University, Szeged, Hungary. | lld:pubmed |
pubmed-article:10422874 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10422874 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10422874 | lld:pubmed |